e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Pulmonary vascular involvement in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Therapeutic update of severe pulmonary hypertension in COPD
A. Chaouat (Vandoeuvre-Les-Nancy, France)
Source:
Annual Congress 2010 - Pulmonary vascular involvement in COPD
Session:
Pulmonary vascular involvement in COPD
Session type:
Symposium
Number:
3605
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Chaouat (Vandoeuvre-Les-Nancy, France). Therapeutic update of severe pulmonary hypertension in COPD. Annual Congress 2010 - Pulmonary vascular involvement in COPD
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Which treatment for which patient with an acute exacerbation of pulmonary hypertension?
Source: Annual Congress 2010 - The acute right heart syndrome in the intensive care unit: a hidden world?
Year: 2010
Current management of patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension updates
Year: 2010
Imaging in assessment of out-of-proportion pulmonary hypertension in patients with COPD
Source: Annual Congress 2010 - Parenchmya and bronchial carcinoma
Year: 2010
Oxygen therapy decreases systemic inflammation in patients with chronic obstructive pulmonary disease and hypoxemia
Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease
Year: 2010
Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013
Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey
Source: International Congress 2014 – Clinical presentations
Year: 2014
Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Peculiarities of intracardiac hemodynamics in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Clinical presentations
Year: 2014
Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Adherence with inhaled respiratory therapeutics is associated with reduced acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD: integrated care and rehabilitation
Year: 2011
Comparison pulmonary rehabilitation efficiency in COPD patients between with and without pulmonary hypertension
Source: International Congress 2014 – Latest insights in pulmonary rehabilitation
Year: 2014
Clinical usefulness of end-tidal CO
2
profiles during rapidly-incremental exercise in patients with idiopathic and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Clinical exercise physiology
Year: 2013
COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators
Source: International Congress 2014 – Clinical presentations
Year: 2014
Comparing cardiopulmonary responses to incremental exercise in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension
Source: Annual Congress 2011 - Altered mechanisms during exercise in disease
Year: 2011
Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015
Characteristics of pulmonary function of COPD with and without arterial pulmonary hypertension
Source: International Congress 2014 – Comorbidities
Year: 2014
Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 427s
Year: 2003
Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept